Volume 40 Issue 1
Jan.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2024  >  40(1): 78-82
XU Ling, PENG Xuemei, DENG Lei, HU Jianju. A Randomized Double-Blind Controlled Clinical Study of Bushen Yuyin Tiaochong Decoction in the Treatment of Diminished Ovarian Reserve Infertility with Kidney-Yin Deficiency[J]. Journal of Nanjing University of traditional Chinese Medicine, 2024, 40(1): 78-82. doi: 10.14148/j.issn.1672-0482.2024.0078
Citation: XU Ling, PENG Xuemei, DENG Lei, HU Jianju. A Randomized Double-Blind Controlled Clinical Study of Bushen Yuyin Tiaochong Decoction in the Treatment of Diminished Ovarian Reserve Infertility with Kidney-Yin Deficiency[J]. Journal of Nanjing University of traditional Chinese Medicine, 2024, 40(1): 78-82. doi: 10.14148/j.issn.1672-0482.2024.0078
shu

A Randomized Double-Blind Controlled Clinical Study of Bushen Yuyin Tiaochong Decoction in the Treatment of Diminished Ovarian Reserve Infertility with Kidney-Yin Deficiency

doi: 10.14148/j.issn.1672-0482.2024.0078

  • The Second Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330012, China

  • Received Date: 2023-09-14
    Available Online: 2024-01-24
    Abstract
  •   OBJECTIVE  To evaluate the clinical effect of Bushen Yuyin Tiaochong Decoction in the treatment of diminished ovarian reserve (DOR) infertility with kidney-yin deficiency.  METHODS  60 DOR infertility patients with kidney-yin deficiency from the gynecology outpatient department of the Second Affiliated Hospital of Jiangxi University of Chinese Medicine from October 2020 to April 2023 were selected and divided into the placebo group and the kidney-tonifying group using the random number table method, with 30 cases in each group. Patients in both groups were given oral treatment with dehydroepiandrosterone (DHEA). The placebo group was additionally given placebo. The Bushen Yuyin group was additionally given Bushen Yuyin Tiaochong Decoction. The treatment course for both groups was 3 months. Changes in TCM syndrome scores and reproductive life quality scores were observed before and after treatment. Changes in serum follicle-stimulating hormone (FSH), anti-Mullerian hormone (AMH) and estradiol (E2) levels in patients were detected by ELISA. The occurrence of adverse reactions during treatment was observed, and the pregnancy rates of the two groups of patients after treatment were recorded.  RESULTS  After treatment, the total TCM syndrome scores of patients in the Bushen Yuyin group were significantly reduced (P < 0.01), which was better than that of the placebo group (P < 0.01); the reproductive life quality scores of patients in both groups were significantly increased (P < 0.05, P < 0.01), the Bushen Yuyin group was better than the placebo group (P < 0.05); the number of AFC in the Bushen Yuyin group was significantly increased (P < 0.01), which was better than the control group (P < 0.01); the serum AMH levels of patients in both groups were significantly increased (P < 0.05, P < 0.01), and the Bushen Yuyin group was higher than that of the placebo group (P < 0.01); the serum E2 level of patients in both groups was significantly decreased (P < 0.05, P < 0.01), the Bushen Yuyin group was lower than the placebo group (P < 0.01); the serum FSH level of patients in Bushen Yuyin group was significantly decreased (P < 0.01), which was better than that of the placebo group (P < 0.01); the total pregnancy rate of the Bushen Yuyin group was better than that of the placebo group (P < 0.05); no significant adverse reactions were observed in both groups during the treatment period.  CONCLUSION  Bushen Yuyin Tiaochong Decoction can significantly improve the pregnancy rate of DOR infertile patients, enhance ovarian function while reducing TCM syndrome scores, improve the quality of reproductive life, and is highly safe.

     

    • FullText(HTML)
  • loading
    • References(21)
  • [1]
    ROMANSKI P A, BORTOLETTO P, ROSENWAKS Z, et al. Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve[J]. Hum Reprod, 2020, 35(7): 1630-1636. doi: 10.1093/humrep/deaa137
    [2]
    Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: A committee opinion[J]. Fertil Steril, 2012, 98(6): 1407-1415. doi: 10.1016/j.fertnstert.2012.09.036
    [3]
    ATA B, SEYHAN A, SELI E. Diminished ovarian reserve versus ovarian aging: Overlaps and differences[J]. Curr Opin Obstet Gynecol, 2019, 31(3): 139-147. doi: 10.1097/GCO.0000000000000536
    [4]
    LEE H, CHOI H J, YANG K M, et al. Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing in vitro fertilization[J]. Obstet Gynecol Sci, 2018, 61(1): 102-110. doi: 10.5468/ogs.2018.61.1.102
    [5]
    徐玲, 张志华, 彭佳华, 等. 育阴补肾方治疗卵巢储备功能减退不孕症的疗效研究[J]. 江西中医药, 2020, 51(4): 42-44.

    XU L, ZHANG Z H, PENG J H, et al. Therapeutic effect of YuyinBushen recipe on infertility caused by hypofunction of ovarian reserve[J]. Jiangxi J Tradit Chin Med, 2020, 51(4): 42-44.
    [6]
    赵晓莉. 补肾调周法联合来曲唑治疗卵泡发育不良的临床研究[D]. 扬州: 扬州大学, 2016.

    ZHAO X L. The clinical study on the effect of combination of TCM and letrozole treatment of follicular maldevelopment[D]. Yangzhou: Yangzhou University, 2016.
    [7]
    CAGLAR A P, KILICDAG E B, HAYDARDEDEOGLU B, et al. Can calcium ionophore "use" in patients with diminished ovarian reserve increase fertilization and pregnancy rates?A randomized, controlled study[J]. Fertil Steril, 2015, 104(5): 1168-1174. doi: 10.1016/j.fertnstert.2015.07.1163
    [8]
    FERRARETTI A P, LA MARCA A, FAUSER B C, et al. ESHRE consensus on the definition of "poor response" to ovarian stimulation for in vitro fertilization: The Bologna criteria[J]. Hum Reprod, 2011, 26(7): 1616-1624. doi: 10.1093/humrep/der092
    [9]
    陈子江, 刘嘉茵, 黄荷凤, 等. 不孕症诊断指南[J]. 中华妇产科杂志, 2019, 54(8): 505-511.

    CHEN Z J, LIU J Y, HUANG H F, et al. Guidelines for diagnosis of infertility[J]. Chin J Obstet Gynecol, 2019, 54(8): 505-511.
    [10]
    马宝璋, 齐聪. 中医妇科学[M]. 北京: 中国医药科技出版社, 2015: 216.

    MA B Z, QI C. Traditional Chinese gynecology[M]. Beijing: China Medical Science Press, 2004.
    [11]
    中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002: 388-390.

    Guiding principles for clinical research of new Chinese medicine: Trial implementation[M]. Beijing: China Medical Science Press, 2002: 388-390.
    [12]
    ZHOU Z, ZHENG D, WU H, et al. Epidemiology of infertility in China: A population-based study[J]. BJOG, 2018, 125(4): 432-441. doi: 10.1111/1471-0528.14966
    [13]
    郑蕾蕾, 丁辉, 李焕, 等. 卵巢储备功能下降研究进展[J]. 辽宁中医药大学学报, 2022, 24(7): 202-208.

    ZHENG L L, DING H, LI H, et al. Research progress of decline in ovarian reserve[J]. J Liaoning Univ Tradit Chin Med, 2022, 24(7): 202-208.
    [14]
    王金玉, 陈圆辉, 王倩, 等. 血清神经肽吻素水平在卵巢储备功能减退不孕症患者中的变化及其诊断价值[J]. 生殖医学杂志, 2022, 31(4): 476-481.

    WANG J Y, CHEN Y H, WANG Q, et al. Diagnostic value and changes of serum Kisspeptin level in women with diminished ovarian reserve[J]. J Reprod Med, 2022, 31(4): 476-481.
    [15]
    周琳, 任梦雪, 秦瑜玲, 等. 基于"气血理论"论治卵巢储备功能下降性不孕[J]. 中国临床医生杂志, 2023, 51(3): 371-373.

    ZHOU L, REN M X, QIN Y L, et al. Treatment of infertility caused by decreased ovarian reserve function based on "qi and blood theory"[J]. Chin J Clin, 2023, 51(3): 371-373.
    [16]
    王冰. 黄帝内经素问[M]. 北京: 人民卫生出版社, 1956: 7-9.

    WANG B. The yellow emperor's inner classic: Basic questions[M]. Beijing: People's Medical Publishing House, 1956: 7-9.
    [17]
    梁瑞宁, 范培, 李佩双, 等. 冲任新说[J]. 中华中医药杂志, 2019, 34(1): 69-71.

    LIANG R N, FAN P, LI P S, et al. New explanation of thoroughfare and conception channels[J]. China J Tradit Chin Med Pharm, 2019, 34(1): 69-71.
    [18]
    唐冬艳. 补肾育阴法治疗肾阴虚型卵泡发育不良性不孕症的临床观察[D]. 南宁: 广西中医药大学, 2022.

    TANG D Y. Clinical observation on the treatment of kidney-Yin deficiency type follicular dysplasia infertility by nourishing the kidney and nourishing Yin[D]. Nanning: Guangxi University of Chinese Medicine, 2022.
    [19]
    赵利亚. 自拟补肾育卵方治疗卵巢储备功能下降(肝肾阴虚证)的临床观察[D]. 长春: 长春中医药大学, 2022.

    ZHAO L Y. Clinical observation on the treatment of decreased ovarian reserve function(liver-kidney Yin deficiency syndrome) by self-made Bushen Yuluan prescription[D]. Changchun: Changchun University of Chinese Medicine, 2022.
    [20]
    宁敏, 李卫红, 顾凤群, 等. 基于数据挖掘中医药治疗卵巢储备功能减退用药规律研究[J]. 现代中西医结合杂志, 2022, 31(2): 214-219.

    NING M, LI W H, GU F Q, et al. Study on the law of traditional Chinese medicine in the treatment of ovarian reserve dysfunction based on data mining[J]. Mod J Integr Tradit Chin West Med, 2022, 31(2): 214-219.
    [21]
    刘柳青, 刘雁峰, 王悦竹, 等. 卵巢储备功能下降中医证型特点及用药规律文献挖掘研究[J]. 中国中医药信息杂志, 2021, 28(6): 33-38.

    LIU L Q, LIU Y F, WANG Y Z, et al. Characteristics of TCM syndromes and medication rules in treatment of diminished ovarian reserve based on data mining[J]. Chin J Inf Tradit Chin Med, 2021, 28(6): 33-38.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (97) PDF downloads(16) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return